Tech Company Financing Transactions
Ironwood Pharmaceuticals Funding Round
On 9/4/2009, Ironwood Pharmaceuticals secured $25 million in funding from Polaris Partners and private investors.
Transaction Overview
Company Name
Announced On
9/4/2009
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Undisclosed
Investors
Polaris Partners (Terrance McGuire)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
100 Summer St. 2300
Boston, MA 02110
USA
Boston, MA 02110
USA
Phone
Website
Email Address
Overview
Ironwood Pharmaceuticals (NasdaqGM: IRWD) is committed to the development of successful human medicines. Drugmaking is not a statistical event, nor simply a high-throughput industrialized pursuit.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mark Mallon
Chief Financial Officer
Gina Consylman
Chief Medical Officer
Michael Shetzline
President
Thomas McCourt
VP - Operations
Jason Rickard
Browse more venture capital transactions:
Prev: 9/4/2009: Daktari Diagnostics venture capital transaction
Next: 9/4/2009: Foursquare venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. All VC database entries on this site are sourced from company press releases and news coverage. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs